123 related articles for article (PubMed ID: 36738834)
1. Pharmacy diabetes screening trial (PDST): Outcomes of a national clustered RCT comparing three screening methods for undiagnosed type 2 diabetes (T2DM) in community pharmacy.
Krass I; Carter R; Mitchell B; Mohebbi M; Shih STF; Trinder P; Versace VL; Wilson F; Mc Namara KP
Diabetes Res Clin Pract; 2023 Mar; 197():110566. PubMed ID: 36738834
[TBL] [Abstract][Full Text] [Related]
2. Participant and GP perspectives and experiences of screening for undiagnosed type 2 diabetes in community pharmacy during the Pharmacy Diabetes Screening Trial.
Krass I; Twigg MJ; Mitchell B; Wilson F; Mohebbi M; Trinder P; Shih STF; Carter R; Versace VL; McNamara K
BMC Health Serv Res; 2023 Dec; 23(1):1337. PubMed ID: 38041094
[TBL] [Abstract][Full Text] [Related]
3. Pharmacy Diabetes Screening Trial: protocol for a pragmatic cluster-randomised controlled trial to compare three screening methods for undiagnosed type 2 diabetes in Australian community pharmacy.
Krass I; Carter R; Mitchell B; Mohebbi M; Shih STF; Trinder P; Versace VL; Wilson F; Namara KM
BMJ Open; 2017 Dec; 7(12):e017725. PubMed ID: 29284715
[TBL] [Abstract][Full Text] [Related]
4. Pharmacy diabetes care program: analysis of two screening methods for undiagnosed type 2 diabetes in Australian community pharmacy.
Krass I; Mitchell B; Clarke P; Brillant M; Dienaar R; Hughes J; Lau P; Peterson G; Stewart K; Taylor S; Wilkinson J; Armour C
Diabetes Res Clin Pract; 2007 Mar; 75(3):339-47. PubMed ID: 16884811
[TBL] [Abstract][Full Text] [Related]
5. Comparison of two methods for assessing diabetes risk in a pharmacy setting in Australia.
Kilkenny MF; Johnson R; Andrew NE; Purvis T; Hicks A; Colagiuri S; Cadilhac DA
BMC Public Health; 2014 Nov; 14():1227. PubMed ID: 25427845
[TBL] [Abstract][Full Text] [Related]
6. Risk assessment and HbA1c measurement in Norwegian community pharmacies to identify people with undiagnosed type 2 diabetes - A feasibility study.
Risøy AJ; Kjome RLS; Sandberg S; Sølvik UØ
PLoS One; 2018; 13(2):e0191316. PubMed ID: 29474501
[TBL] [Abstract][Full Text] [Related]
7. Diabetes and cardiovascular disease risk screening model in community pharmacies in a developing primary healthcare system: a feasibility study.
Alzubaidi HT; Chandir S; Hasan S; McNamara K; Cox R; Krass I
BMJ Open; 2019 Nov; 9(11):e031246. PubMed ID: 31712336
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of men classified at high-risk for type 2 diabetes mellitus using the AUSDRISK screening tool.
Aguiar EJ; Morgan PJ; Collins CE; Plotnikoff RC; Callister R
Diabetes Res Clin Pract; 2015 Apr; 108(1):45-54. PubMed ID: 25707921
[TBL] [Abstract][Full Text] [Related]
9. Implementation of diabetes screening in community pharmacy - factors influencing successful implementation.
Siu AHY; Krass I; Mitchell B; McNamara K
Res Social Adm Pharm; 2021 Sep; 17(9):1606-1613. PubMed ID: 33414090
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of a collaborative diabetes screening campaign between community pharmacies and general practitioners.
Murteira R; Cary M; Galante H; Romano S; Guerreiro JP; Rodrigues AT
Prim Care Diabetes; 2023 Aug; 17(4):314-320. PubMed ID: 37156696
[TBL] [Abstract][Full Text] [Related]
11. Screening for type 2 diabetes with random finger-prick glucose and bedside HbA1c in an Australian emergency department.
Jelinek GA; Weiland TJ; Moore G; Tan G; Maslin M; Bowman K; Ward G; O'Dea K
Emerg Med Australas; 2010 Oct; 22(5):427-34. PubMed ID: 21040483
[TBL] [Abstract][Full Text] [Related]
12. Improving pharmaceutical practice in diabetes care using point-of-care glycated haemoglobin testing in the community pharmacy.
Santana CR; de Oliveira MGG; Camargo MS; Moreira PMB; de Castro PR; Aguiar EC; Mistro S
Int J Pharm Pract; 2024 Feb; 32(1):46-51. PubMed ID: 37936510
[TBL] [Abstract][Full Text] [Related]
13. Prediabetes, undiagnosed diabetes and diabetes risk in Italy in 2017-2018: results from the first National screening campaign in community pharmacies.
Brunetti P; Baldessin L; Pagliacci S
J Public Health (Oxf); 2022 Aug; 44(3):499-506. PubMed ID: 33837433
[TBL] [Abstract][Full Text] [Related]
14. Screening for type 2 diabetes: a short report for the National Screening Committee.
Waugh NR; Shyangdan D; Taylor-Phillips S; Suri G; Hall B
Health Technol Assess; 2013 Aug; 17(35):1-90. PubMed ID: 23972041
[TBL] [Abstract][Full Text] [Related]
15. Quality Control of Norwegian Pharmacy HbA1c Testing: A Modest Beginning.
Ørvim Sølvik U; Risøy AJ; Kjome RLS; Sandberg S
J Diabetes Sci Technol; 2018 Jul; 12(4):753-761. PubMed ID: 29619895
[TBL] [Abstract][Full Text] [Related]
16. Using the AUSDRISK score to screen for pre-diabetes and diabetes in GP practices: a case-finding approach.
Fleming K; Weaver N; Peel R; Hure A; McEvoy M; Holliday E; Parsons M; Acharya S; Luu J; Wiggers J; Rissel C; Ranasinghe P; Jayawardena R; Samman S; Attia J
Aust N Z J Public Health; 2022 Apr; 46(2):203-207. PubMed ID: 34762354
[TBL] [Abstract][Full Text] [Related]
17. Assessment of diabetes knowledge, screening and uptake of community diabetes programs in a peri-urban region in Australia.
Osuagwu UL; Sharma S; Silva D; Saunders J; Pillay J; Piya MK; Simmons D
Diabetes Metab Syndr; 2021; 15(5):102257. PubMed ID: 34425557
[TBL] [Abstract][Full Text] [Related]
18. Screening for type 2 diabetes: literature review and economic modelling.
Waugh N; Scotland G; McNamee P; Gillett M; Brennan A; Goyder E; Williams R; John A
Health Technol Assess; 2007 May; 11(17):iii-iv, ix-xi, 1-125. PubMed ID: 17462167
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of a novel pharmacy screening intervention to address the burden of type 2 diabetes and cardiovascular disease in an Arabic-speaking country.
Alzubaidi H; Hasan S; Saidawi W; Mc Namara K; Chandir S; Krass I
Diabet Med; 2021 Aug; 38(8):e14598. PubMed ID: 33969536
[TBL] [Abstract][Full Text] [Related]
20. Assessment of a screening protocol for type 2 diabetes in community pharmacy. The DiabNow Study.
Fikri-Benbrahim N; Martínez-Martínez F; Saéz-Benito L; Luque BS; Corpas JP; Moullin JC; Sabater-Hernández D
Diabetes Res Clin Pract; 2015 Jun; 108(3):e49-52. PubMed ID: 25819481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
